Medizinische Universität Graz - Research portal
Schippinger Walter |
** = Publications listed in SCI/SSCI/Pubmed
2024
Full paper/article (Journal)
** König, E; Kriegl, L; Pux, C; Uhlmann, M; Schippinger, W; Avian, A; Krause, R; Zollner-Schwetz, I
Implementation of an antimicrobial stewardship program for urinary tract infections in long-term care facilities: a cluster-controlled intervention study.
Antimicrob Resist Infect Control. 2024; 13(1): 43
Doi: 10.1186/s13756-024-01397-2
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Full paper/article (Journal)
** König, E; Medwed, M; Pux, C; Uhlmann, M; Schippinger, W; Krause, R; Zollner-Schwetz, I
Prospective Surveillance of Healthcare-Associated Infections in Residents in Four Long-Term Care Facilities in Graz, Austria.
Antibiotics (Basel). 2021; 10(5):
Doi: 10.3390/antibiotics10050544
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Libiseller, A; Lichtenegger, KM; de, Campo, A; Wiesinger, T; Cuder, G; Donsa, K; Höll, B; Beck, P; Plank, J; Schippinger, W; Pieber, TR
Diabetes Management According to Health Status in Older Adults with Type 2 Diabetes Staying in Geriatric Care Facilities.
J Diabetes Sci Technol. 2021; 15(3):615-621
Doi: 10.1177/1932296820905827
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zollner-Schwetz, I; König, E; Krause, R; Pux, C; Laubreiter, L; Schippinger, W
Analysis of COVID-19 outbreaks in 3 long-term care facilities in Graz, Austria.
Am J Infect Control. 2021; 49(11):1350-1353
Doi: 10.1016/j.ajic.2021.08.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Lukasiak, K; Stranz, B; Thurner, E; Stranzl-Lawatsch, H; Schippinger, W; Langsenlehner, U; Langsenlehner, T
Evaluation of the biological age in PCa patients treated with RT using a geriatric assessment
RADIOTHER ONCOL. 2021; 161: S1189-S1189.
[Poster]
Web of Science
2020
Full paper/article (Journal)
** Leitner, E; Schreiner, E; Neuhold, M; Bozic, M; Pux, C; Pichler, G; Schippinger, W; Steinmetz, I; Krause, R; Zollner-Schwetz, I
Low prevalence of Clostridium difficile colonization in patients in long-term care facilities in Graz, Austria: A point-prevalence study.
Am J Infect Control. 2020; 48(10):1144-1147
Doi: 10.1016/j.ajic.2019.12.011
Web of Science
PubMed
FullText
FullText_MUG
** Stadlbauer, V; Engertsberger, L; Komarova, I; Feldbacher, N; Leber, B; Pichler, G; Fink, N; Scarpatetti, M; Schippinger, W; Schmidt, R; Horvath, A
Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study.
BMC Geriatr. 2020; 20(1):248-248
Doi: 10.1186/s12877-020-01644-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** König, E; Pux, C; Schippinger, W; Stoiser, E; Krause, R; Zollner-Schwetz, I
Increasing influenza vaccination rates among health care workers and residents of long-term care facilities for the elderly in Graz, Austria.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):79-79.-Österreichische Gesellschaft für Innere Medizin ; Sept 24-26, 2020; Salzburg, Austria.
[Poster]
Web of Science
** Lichtenegger, K; Kopanz, J; Libiseller, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Beck, P; Holl, B; Pieber, T; De Campo, A
DIGITAL DECISION SUPPORT FOR BASAL INSULIN THERAPY: RCT CONFIRMED READINESS FOR IMPLEMENTATION IN ACUTE-GERIATRIC CARE PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A110-A111.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-22, 2020; Madrid, SPAIN.
[Poster]
Web of Science
2019
Abstract (Journal)
** Donsa, K; Stampfer, P; Truskaller, T; Kopanz, J; Konig, C; Lichtenegger, K; Mrak, P; Pinter, G; Schippinger, W; Sinner, F
Development of an innovative eHealth System for comprehensive Quality Assurance and Therapy Support in Austrian Institutions of Acute Geriatrics and Remobilization - Presentation of a user-centered Development Process
Z GERONTOL GERIATR. 2019; 52: S158-S158.
[Poster]
Web of Science
** Libiseller, A; Lichtenegger, KM; Kopanz, J; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, BC; Beck, P; Holl, B; Pieber, TR
Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System
DIABETES. Diabetes 2019 Jun; 68(Supplement 1): -. . 2019; 68: -79th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 07-11, 2019; San Francisco, CA.
Doi: 10.2337/db19-952-P
[Poster]
Web of Science
FullText
FullText_MUG
2018
Full paper/article (Journal)
** Schippinger, W; Glechner, A; Horvath, K; Sommeregger, U; Fruhwald, T; Dovjak, P; Pinter, G; Iglseder, B; Mrak, P; Muller, W; Ohrenberger, G; Mann, E; Bohmdorfer, B; Roller-Wirnsberger, R
Optimizing medical care for geriatric patients in Austria: defining a top five list of "Choosing Wisely" recommendations using the Delphi technique
EUR GERIATR MED. 2018; 9(6): 783-793.
Doi: 10.1007/s41999-018-0105-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Abstract (Journal)
** Gschwandtner, E; Faffelberger, C; Lindenmann, J; Fink-Neubock, N; Fediuk, M; Schippinger, W; Bitsche, S; Porubsky, C; Smolle-Juttner, FM
Quality of Life in palliative patients with lung cancer in a palliative setting
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):775-775.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie- 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA.
[Poster]
Web of Science
2016
Full paper/article (Journal)
** Landsmann, B; Pinter, D; Pirker, E; Pichler, G; Schippinger, W; Weiss, EM; Mathie, G; Gattringer, T; Fazekas, F; Enzinger, C
An exploratory intervention study suggests clinical benefits of training in chronic stroke to be paralleled by changes in brain activity using repeated fMRI.
Clin Interv Aging. 2016; 11(3):97-103
Doi: 10.2147/CIA.S95632
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Zollner-Schwetz, I; Zechner, E; Ullrich, E; Pux, C; Pichler, G; Schippinger, W; Krause, R; Leitner, E
Colonization with multidrug-resistant Gram-negative bacteria in long time care facilities: prevalence and risk factors
WIEN KLIN WOCHENSCHR. 2016; 128: S387-S388.
[Poster]
Web of Science
2015
Full paper/article (Journal)
** Kandioler, D; Mittlböck, M; Kappel, S; Puhalla, H; Herbst, F; Langner, C; Wolf, B; Tschmelitsch, J; Schippinger, W; Steger, G; Hofbauer, F; Samonigg, H; Gnant, M; Teleky, B; Kührer, I; p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG)
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine. 2015; 2(8):825-830
Doi: 10.1016/j.ebiom.2015.06.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Landsmann, B; Pinter, D; Pirker, E; Wallack, E; Pichler, G; Schippinger, W; Ropele, S; Gattringer, T; Fazekas, F; Enzinger, C
An exploratory intervention study suggests clinical benefits of training in chronic stroke to be paralleled by changes in brain activity using repeated fMRI
EUR J NEUROL. 2015; 22: 407-407.-1st Congress of the European-Academy-of-Neurology; June 20-23, 2015; Berlin, Germany.
[Poster]
Web of Science
2014
Full paper/article (Journal)
** Horki, P; Bauernfeind, G; Klobassa, DS; Pokorny, C; Pichler, G; Schippinger, W; Müller-Putz, GR
Detection of mental imagery and attempted movements in patients with disorders of consciousness using EEG.
Front Hum Neurosci. 2014; 8(4):1009-1009
Doi: 10.3389/fnhum.2014.01009
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Full paper/article (Journal)
** Hofmann, G; Balic, M; Dandachi, N; Resel, M; Schippinger, W; Regitnig, P; Samonigg, H; Bauernhofer, T
The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Clin Biochem. 2013; 46(15):1585-1589
Doi: 10.1016/j.clinbiochem.2013.06.010
Web of Science
PubMed
FullText
FullText_MUG
2012
Full paper/article (Journal)
** Heitzer, E; Sandner-Kiesling, A; Schippinger, W; Stohscheer, I; Osprian, I; Bitsche, S; Eisner, F; Verebes, J; Hofmann, G; Samonigg, H
IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer.
Pain Physician. 2012; 15(6):499-510
Doi: 10.36076/ppj.2012/15/499
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schippinger, W; Hartinger, G; Hierzer, A; Osprian, I; Bohnstingl, M; Pilgram, EH
Mobile geriatric consultant services for rest homes. Study of the effects of consultations by internal medicine specialists in the medical care of rest home residents].
Z Gerontol Geriatr. 2012; 45(8):735-741
Doi: 10.1007/s00391-012-0395-2
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The Functional Polymorphism of Erythropoietin Gene rs1617640 G>T Is Not Associated with Susceptibility and Clinical Outcome of Early-stage Breast Cancer.
Anticancer Res. 2012; 32(8):3473-3478
Web of Science
PubMed
Abstract (Journal)
** Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
[Poster]
Web of Science
2009
Full paper/article (Journal)
** Filipits, M; Rudas, M; Heinzl, H; Jakesz, R; Kubista, E; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Nader, A; Stierer, M; Gnant, MF; Austrian Breast and Colorectal Cancer Study Group
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Clin Cancer Res. 2009; 15(18):5888-5894
Doi: 10.1158/1078-0432.CCR-09-0728
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691
Doi: 10.1056/NEJMoa0806285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Poestlberger, S; Menzel, C; Jakesz, R; Kubista, E; Marth, C; Greil, R
ADDITION OF ZOLEDRONIC ACID (ZOL) TO ADJUVANT ENDOCRINE THERAPY IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (HREBC): MULTIVARIATE ANALYSES OF THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP 12 (ABCSG-12) TRIAL
ANN ONCOL. 2009; 20: 30-30.-IMPAKT Breast Cancer Conference; MAY 7-9, 2009; Brussels, BELGIUM.
[Poster]
Web of Science
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, G; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
The number needed to treat (NNT) as a measure of drug efficacy: the case of zoledronic acid for early hormone-responsive breast cancer in the ABCSG-12 trial
CANCER RES. 2009; 69(2):191S-191S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX.
[Oral Communication]
Web of Science
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, G; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial
BREAST. 2009; 18: S59-S59.
Doi: 10.1016/S0960-9776(09)70187-0
Web of Science
FullText
FullText_MUG
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, GG; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
NUMBER NEEDED TO TREAT (NNT) AS A MEASURE OF ZOLEDRONIC ACID (ZOL) EFFICACY IN PATIENTS WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (BC) IN THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12 TRIAL
ANN ONCOL. 2009; 20: 30-30.
Web of Science
2008
Full paper/article (Journal)
** Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M; Austrian Breast and Colorectal Cancer Study Group
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res. 2008; 14(7):2082-2087
Doi: 10.1158/1078-0432.CCR-07-2068
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774.
Doi: 10.1158/1078-0432.CCR-07-4122
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schmid, P; Kühnhardt, D; Kiewe, P; Lehenbauer-Dehm, S; Schippinger, W; Greil, R; Lange, W; Preiss, J; Niederle, N; Brossart, P; Freier, W; Kümmel, S; Van de Velde, H; Regierer, A; Possinger, K
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
Ann Oncol. 2008; 19(5):871-876
Doi: 10.1093/annonc/mdm569
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Taucher, S; Steger, GG; Jakesz, R; Tausch, C; Wette, V; Schippinger, W; Kwasny, W; Reiner, G; Greil, R; Dubsky, P; Poestlberger, S; Tschmelitsch, J; Samonigg, H; Gnant, M; Austrian Breast and Colorectal Cancer Study Group-07
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Breast Cancer Res Treat. 2008; 112(2): 309-316.
Doi: 10.1007/s10549-007-9844-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Steger, GG; Bjelic-Radisic, V; Jakesz, R; Kubista, E; Marth, C; Greil, R
ZOLEDRONIC ACID (ZOL) IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (ERBC) RECEIVING ADJUVANT ENDOCRINE THERAPY: MULTIVARIATE ANALYSIS OF EFFICACY DATA FROM THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP (ABCSG)-12
ANN ONCOL. 2008; 19: 44-44.-33rd European-Society-for-Medical-Oncology Congress; SEP 12-16, 2008; Stockholm, SWEDEN.
[Keynote lecture]
Web of Science
** Spat, S; Habacher, W; Rakovac, I; Baumgartner, J; Schippinger, W; Samonigg, H; Pieber, TR
SHIFT OF PUBLIC HEALTH CARE EXPENDITURES FOR PALLIATIVE CANCER PATIENTS FROM INPATIENT TO OUTPATIENT EFFECTED BY HOME CARE SUPPORT TEAMS PROVIDED BY A UNIVERSITY HOSPITAL IN AUSTRIA
VALUE HEALTH. 2008; 11(6):A479-A480.
Doi: 10.1016/S1098-3015(10)66600-4
[Oral Communication]
Web of Science
FullText
FullText_MUG
2007
Full paper/article (Journal)
** Asslaber, M; Abuja, PM; Stark, K; Eder, J; Gottweis, H; Trauner, M; Samonigg, H; Mischinger, HJ; Schippinger, W; Berghold, A; Denk, H; Zatloukal, K
The Genome Austria Tissue Bank (GATiB).
Pathobiology. 2007; 74(4):251-258
Doi: 10.1159/000104453
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Neumann, R; Samonigg, H; Bauernhofer, T
The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Am J Clin Pathol. 2007; 128(4):630-637
Doi: 10.1309/51KPD70348RP6XTE
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schippinger, W; Samonigg, H; Schaberl-Moser, R; Greil, R; Thödtmann, R; Tschmelitsch, J; Jagoditsch, M; Steger, GG; Jakesz, R; Herbst, F; Hofbauer, F; Rabl, H; Wohlmuth, P; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
BRIT J CANCER. 2007; 97(8): 1021-1027.
Doi: 10.1038/sj.bjc.6604011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kaessmann, H; Piswanger-Soelkner, C; Seifert, M; Schippinger, W; Menzel, C; Dubsky, P; Fitzal, F; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Jakesz, R
Bone mineral density (BMD) at 5 years after diagnosis in premenopausal patients with endocrine-responsive breast cancer, after 3 years of adjuvant endocrine treatment with goserelin and tamoxifen or anastrozole or both treatments in combination with zoledronic acid - new results from ABCSG-12
BREAST CANCER RES TREAT. 2007; 106: S8-S8.
[Oral Communication]
Web of Science
** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T
Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
BREAST CANCER RES. 2007; 9(1):
Doi: 10.1186/bcr1722
[Poster]
Web of Science
FullText
FullText_MUG
** Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
2006
Full paper/article (Journal)
** Hofmann, G; Bauernhofer, T; Krippl, P; Lang-Loidolt, D; Horn, S; Goessler, W; Schippinger, W; Ploner, F; Stoeger, H; Samonigg, H
Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
BMC Cancer. 2006; 6(2):1-1
Doi: 10.1186/1471-2407-6-1
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T; Samonigg, H
Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Oncology. 2006; 70(4):290-293
Doi: 10.1159/000094890
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schippinger, W; Regitnig, P; Dandachi, N; Wernecke, KD; Bauernhofer, T; Samonigg, H; Moinfar, F
Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.
Virchows Arch. 2006; 449(1):24-30
Doi: 10.1007/s00428-006-0213-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schneider, J; Ruschhaupt, M; Buness, A; Asslaber, M; Regitnig, P; Zatloukal, K; Schippinger, W; Ploner, F; Poustka, A; Sültmann, H
Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.
Int J Cancer. 2006; 119(12):2974-2979
Doi: 10.1002/ijc.22234
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Gnant, M; Greil, R; Kubista, E; Menzel, C; Schippinger, W; Seifert, M; Haider, K; Mlineritsch, B; Samonigg, H; Kwasny, W; Fridrik, M; Steger, G; Steindorfer, P; Schmelitsch, J; Poetter, R; Jakesz, R
The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year results of ABCSG-05 (CMF vs. goserelin plus tamoxifen).
BREAST CANCER RES TREAT. 2006; 100: S10-S11.
[Poster]
Web of Science
** Steger, GG; Greil, R; Samonigg, H; Jakesz, R; Bartsch, R; Mlineritsch, B; Melbinger-Zeinitzer, E; Marth, C; Schippinger, W; Gnant, MF
An interim safety analysis of ABCSG-24: 6 cycles of docetaxel, epirubicin, and capecitabine plus pegfilgrastim (DEC) vs. 6 cycles of docetaxel and epirubicin plus pegfilgrastim (DE) in the neoadjuvant treatment of operable breast cancer.
BREAST CANCER RES TREAT. 2006; 100: S156-S156.
[Poster]
Web of Science
2005
Full paper/article (Journal)
** Schippinger, W; Jagoditsch, M; Sorré, C; Gnant, M; Steger, G; Hausmaninger, H; Mlineritsch, B; Schaberl-Moser, R; Mischinger, HJ; Hofbauer, F; Holzberger, P; Mittlböck, M; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
BRIT J CANCER. 2005; 92(9): 1655-1662.
Doi: 10.1038/sj.bjc.6602555
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schmid, P; Schippinger, W; Nitsch, T; Huebner, G; Heilmann, V; Schultze, W; Hausmaninger, H; Wischnewsky, M; Possinger, K
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
J Clin Oncol. 2005; 23(3):432-440
Doi: 10.1200/JCO.2005.06.072
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T
Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science
** Possinger, K; Schippinger, W; Kiewe, P; Lange, W; Preiss, J; Niederle, N; Brossart, P; Papke, J; Freier, W; de Velde, HV; Schmid, P
Phase I trial of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
J CLIN ONCOL 2005 23: 66S-66S.
Web of Science
** Schmid, P; Schippinger, V; Kiewe, P; Lange, W; Preiss, J; Niederle, N; Brossart, P; Freier, W; Van de Velde, H; Possinger, K
Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
BREAST CANCER RES TREAT 2005 94: -.
Web of Science
2004
Full paper/article (Journal)
** Regitnig, P; Schippinger, W; Lindbauer, M; Samonigg, H; Lax, SF
Change of HER-2/neu status in a subset of distant metastases from breast carcinomas.
J PATHOL. 2004; 203(4): 918-926.
Doi: 10.1002/path.1592
Web of Science
PubMed
FullText
FullText_MUG
** Schippinger, W; Regitnig, P; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Wehrschütz, M; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
ONCOL REP. 2004; 11(6): 1331-1336.
Doi: 10.3892/or.11.6.1331
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Schmid, P; Schippinger, W; Nitsch, T; Huebner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, M; Samonigg, H; Possinger, K
Up-front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial.
J CLIN ONCOL 2004 22: 37S-37S.
Web of Science
2003
Abstract (Journal)
** Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
** Schmid, P; Schippinger, W; Nitsch, T; Huenbner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, MB; Luftner, D; Samonigg, H; Possinger, K
Up front tandem high-dose chemotherapy compared to standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: updated results of a randomized trial
BREAST CANCER RES TREAT 2003 82: S152-S152.
Web of Science
2002
Abstract (Journal)
** Ploner, F; Genser, B; Schippinger, W; Hofmann, G; Samonigg, H
The influence of prognostic factors seems to be constant throughout the course of metastatic breast cancer regardless of therapeutical intervention.
BREAST CANCER RES TREAT. 2002; 76: S48-S48.
Web of Science
** Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
2001
Full paper/article (Proceedings)
** Kronberger, L; Wagner, P; Puchinger, M; Stranzl, H; Lax, SF; Kohek, P; Linck, FG; Schippinger, W; Thalhammer, M; Rigler, N; Hoss, G; Samonigg, H; Mischinger, HJ; Kapp, K; Rehak, P; Smola, M
Radiofrequency-hyperthermia in combination with chemo- and radiotherapy in palliative treatment of breast cancer - A case report
In: Mozzillo, N, Parisi, V. editors(s). 2ND CANCER SYMPOSIUM - SELECTED FREE PAPERS; 17-21. (ISBN: 88-323-1919-5) ( Presented at: 2nd Cancer Symposium, NAPLES, ITALY, SEP 19-22, 2001)
Web of Science
1999
Abstract (Journal)
** Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science
1995
Full paper/article (Journal)
** Schippinger, W; Buchinger, W; Schubert, B; Költringer, P; Eber, O
Late potentials in high resolution ECG in thyroid gland dysfunction
Acta Med Austriaca. 1995; 22(4):73-74
Web of Science
PubMed